Literature DB >> 9846985

Uroplakin gene expression by normal and neoplastic human urothelium.

E D Lobban1, B A Smith, G D Hall, P Harnden, P Roberts, P J Selby, L K Trejdosiewicz, J Southgate.   

Abstract

cDNA sequences for human uroplakins UPIa, UPIb, UPII, and UPIII were cloned and used to investigate uroplakin transcription by normal and neoplastic urothelial cells. Normal urothelium expressed mRNA for all four uroplakins, although UPIII could be detected only by ribonuclease protection assay. By in situ hybridization, UPIa and UPII were confined to superficial cells and UPIb was also expressed by intermediate cells. Cultured normal human urothelial cells showed a proliferative basal/intermediate cell phenotype and constitutive expression of UPIb only. Uroplakin expression by transitional cell carcinoma cell lines was related to their differentiated phenotype in vitro. RT4 cells expressed all uroplakins, VM-CUB-3 expressed three uroplakins, RT112 and HT1376 cells expressed only UPIb in high abundance, and COLO232, KK47, and EJ cells had no detectable expression. These results correlated with patterns of uroplakin expression in tumors. UPIa and UPII were detected superficially only in well differentiated transitional cell carcinoma papillae. UPIb was positive in seven of nine and overexpressed in five of nine noninvasive transitional cell carcinomas and was also present in four of eight invasive transitional cell carcinomas. Lymph node metastases retained the same pattern of UPIb expression as the primary tumor. Unlike the three differentiation-regulated uroplakins, UPIb may have an alternative role in urothelial cell/tissue processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846985      PMCID: PMC1866332          DOI: 10.1016/S0002-9440(10)65709-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

Review 1.  Urothelial tissue regulation. Unraveling the role of the stroma.

Authors:  J Southgate; P Harnden; P J Selby; D F Thomas; L K Trejdosiewicz
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization.

Authors:  L K Trejdosiewicz; J Southgate; J A Donald; J R Masters; P J Hepburn; G M Hodges
Journal:  J Urol       Date:  1985-03       Impact factor: 7.450

3.  Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines.

Authors:  J R Masters; P J Hepburn; L Walker; W J Highman; L K Trejdosiewicz; S Povey; M Parkar; B T Hill; P R Riddle; L M Franks
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

4.  Species cross-reactive membrane-associated urothelial differentiation antigen.

Authors:  L K Trejdosiewicz; P D Wilson; G M Hodges
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

5.  Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.

Authors:  P Ponte; S Y Ng; J Engel; P Gunning; L Kedes
Journal:  Nucleic Acids Res       Date:  1984-02-10       Impact factor: 16.971

6.  Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.

Authors:  R L Wu; I Osman; X R Wu; M L Lu; Z F Zhang; F X Liang; R Hamza; H Scher; C Cordon-Cardo; T T Sun
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

7.  Normal human urothelial cells in vitro: proliferation and induction of stratification.

Authors:  J Southgate; K A Hutton; D F Thomas; L K Trejdosiewicz
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

8.  Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11.

Authors:  N B Atkin; M C Baker
Journal:  Cancer Genet Cytogenet       Date:  1985-02-15

9.  Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins.

Authors:  X R Wu; J H Lin; T Walz; M Häner; J Yu; U Aebi; T T Sun
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

10.  Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane.

Authors:  J H Lin; X R Wu; G Kreibich; T T Sun
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

View more
  35 in total

1.  Gene expression in the normal adult human kidney assessed by complementary DNA microarray.

Authors:  John P T Higgins; Lingli Wang; Neeraja Kambham; Kelli Montgomery; Veronica Mason; Stefanie U Vogelmann; Kevin V Lemley; Patrick O Brown; James D Brooks; Matt van de Rijn
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

2.  Cloning of human uroplakin II gene from Chinese transitional cell carcinoma of bladder and construction of its eukaryotic expression vector.

Authors:  Fangmin Chen; Fuqing Zeng; Qiangsong Tong; Liduan Zheng; Liang Wang; Jihua Dong; Gongcheng Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering.

Authors:  Hong Tian; Shantaram Bharadwaj; Yan Liu; Peter X Ma; Anthony Atala; Yuanyuan Zhang
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

4.  Expression and localization of four uroplakins in urothelial preneoplastic lesions.

Authors:  Daša Zupančič; Maja Zakrajšek; Ge Zhou; Rok Romih
Journal:  Histochem Cell Biol       Date:  2011-08-19       Impact factor: 4.304

5.  Downregulation of UPK1A suppresses proliferation and enhances apoptosis of bladder transitional cell carcinoma cells.

Authors:  Haiyan Zhu; Yuxin Tang; Xiangyang Zhang; Xianzhen Jiang; Yong Wang; Yu Gan; Jianfu Yang
Journal:  Med Oncol       Date:  2015-02-21       Impact factor: 3.064

6.  Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.

Authors:  Claire Lucy Varley; Jens Stahlschmidt; Barbara Smith; Michael Stower; Jennifer Southgate
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.

Authors:  Andrea E Varga; Lefta Leonardos; Paul Jackson; Alexandra Marreiros; Prue A Cowled
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

8.  Increased cancer risk of augmentation cystoplasty: possible role for hyperosmolal microenvironment on DNA damage recognition.

Authors:  Bradley P Dixon; Albert Chu; Jeff Henry; Rebecca Kim; John J Bissler
Journal:  Mutat Res       Date:  2009-07-30       Impact factor: 2.433

Review 9.  Uroplakins in urothelial biology, function, and disease.

Authors:  Xue-Ru Wu; Xiang-Peng Kong; Angel Pellicer; Gert Kreibich; Tung-Tien Sun
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

10.  Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.

Authors:  Hong-Ying Huang; Shahrokh F Shariat; Tung-Tien Sun; Herbert Lepor; Ellen Shapiro; Jer-Tsong Hsieh; Raheela Ashfaq; Yair Lotan; Xue-Ru Wu
Journal:  Hum Pathol       Date:  2007-08-17       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.